UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 72

Sortiert nach

Making sense of G-quadruplex and i-motif functions in oncogene promoters

The FEBS journal, 2010-09, Vol.277 (17), p.3459-3469

2010

Volltextzugriff (PDF)

The i-Motif as a Molecular Target: More Than a Complementary DNA Secondary Structure

Pharmaceuticals, 2021-01, Vol.14 (2), p.96

2021

Volltextzugriff (PDF)

Identification of natural compounds tubercidin and lycorine HCl against small‐cell lung cancer and BCAT1 as a therapeutic target

Journal of cellular and molecular medicine, 2022-05, Vol.26 (9), p.2557-2565

2022

Volltextzugriff (PDF)

Simultaneous Drug Targeting of the Promoter MYC G‑Quadruplex and BCL2 i‑Motif in Diffuse Large B‑Cell Lymphoma Delays Tumor Growth

Journal of medicinal chemistry, 2017-08, Vol.60 (15), p.6587-6597

2017

Volltextzugriff (PDF)

Oncolytic strategy using new bifunctional HDACs/BRD4 inhibitors against virus-associated lymphomas

PLoS pathogens, 2023-01, Vol.19 (1), p.e1011089

2023

Volltextzugriff (PDF)

The role of G-quadruplex/i-motif secondary structures as cis-acting regulatory elements

Pure and applied chemistry, 2010, Vol.82 (8), p.1609-1621

2010

Volltextzugriff (PDF)

Targeting a Novel G-Quadruplex in the CARD11 Oncogene Promoter with Naptho(2,1-b)furan-1-ethanol,2-nitro- Requires the Nitro Group

Genes, 2022-06, Vol.13 (7), p.1144

2022

Volltextzugriff (PDF)

The Transcriptional Complex Between the BCL2 i‑Motif and hnRNP LL Is a Molecular Switch for Control of Gene Expression That Can Be Modulated by Small Molecules

Journal of the American Chemical Society, 2014-03, Vol.136 (11), p.4172-4185

2014

Volltextzugriff (PDF)

The Anti-COVID-19 Drug Remdesivir Promotes Oncogenic Herpesvirus Reactivation through Regulation of Intracellular Signaling Pathways

Antimicrobial agents and chemotherapy, 2022-03, Vol.66 (3), p.e0239521-e0239521

2022

Volltextzugriff (PDF)

G4 Biology

1, 2024

Volltextzugriff (PDF)

Mechanistic Insights into Chemoresistance Mediated by Oncogenic Viruses in Lymphomas

Viruses, 2019-12, Vol.11 (12), p.1161

2019

Volltextzugriff (PDF)

The Dynamic Character of the BCL2 Promoter i‑Motif Provides a Mechanism for Modulation of Gene Expression by Compounds That Bind Selectively to the Alternative DNA Hairpin Structure

Journal of the American Chemical Society, 2014-03, Vol.136 (11), p.4161-4171

2014

Volltextzugriff (PDF)

Development of Humanized Diffuse Large B-Cell Lymphoma Mouse Models

Blood, 2021-11, Vol.138 (Supplement 1), p.4501-4501

2021

Volltextzugriff (PDF)

Discovery of DNA G-Quadruplexes As a New Target for B-Cell Receptor Signaling Inhibition in Diffuse Large B-Cell Lymphoma

Blood, 2018-11, Vol.132 (Supplement 1), p.3502-3502

2018

Volltextzugriff (PDF)

Synergistic induction of apoptosis in high-risk DLBCL by BCL2 inhibition with ABT-199 combined with pharmacologic loss of MCL1

Leukemia, 2015-08, Vol.29 (8), p.1702-1712

2015

Volltextzugriff (PDF)

The i-Motif in the bcl-2 P1 Promoter Forms an Unexpectedly Stable Structure with a Unique 8:5:7 Loop Folding Pattern

Journal of the American Chemical Society, 2009-12, Vol.131 (48), p.17667-17676

2009

Volltextzugriff (PDF)

Concomitant Deletion of Short Arm (del 1p) and Amplification or Gain (1q21) of Chromosome 1 By Fluorescence in Situ Hybridization (FISH) Is Associated with Poor Clinical Outcome

Blood, 2021-11, Vol.138 (Supplement 1), p.1627-1627

2021

Volltextzugriff (PDF)

Concurrent Targeting of BCL2 and MYC Transcription Leads to Chemo-Sensitization of Dual-Expressing Diffuse Large B-Cell Lymphoma In Vivo

Blood, 2016-12, Vol.128 (22), p.4090-4090

2016

Volltextzugriff (PDF)

Frequent expression of activation-induced cytidine deaminase in diffuse large B-cell lymphoma tissues from persons living with HIV

AIDS (London), 2020-11, Vol.34 (14), p.2025-2035

2020

Volltextzugriff (PDF)

Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma

Molecular cancer therapeutics, 2024-03, Vol.23 (3), p.316

2024

Volltextzugriff (PDF)

Enhanced DNA repair and genomic stability identify a novel HIV‐related diffuse large B‐cell lymphoma signature

International journal of cancer, 2019-12, Vol.145 (11), p.3078-3088

2019

Volltextzugriff (PDF)

Late Relapsing Multiple Myeloma ≥ 10 Years after Treatment on Total Therapy Protocols Are Associated with Good Outcome

Blood, 2020-11, Vol.136 (Supplement 1), p.11-12

2020

Volltextzugriff (PDF)

Concurrent BCL2/MYC Gene Amplification Associates with Increased DNA G-Quadruplex Formation in DLBCL

Blood, 2015-12, Vol.126 (23), p.2641-2641

2015

Volltextzugriff (PDF)

Abstract LB-46: Chemo-sensitization by modulation of Bcl-2 expression: The first example of an i-motif interactive small molecule that modulates gene expression

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.LB-46-LB-46

2010

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(66)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(48)
Life Sciences & Biomedicine
(41)
Humans
(39)
Female
(14)
Male
(13)
Patients
(11)
Middle Aged
(10)
Adult
(9)
Gene Expression
(9)
Primary Care
(9)
Animals
(8)
Lymphoma
(8)
Antidepressants
(7)
Lymphoma, Large B-Cell, Diffuse - Genetics
(7)
Mental Depression
(7)
Qualitative Research
(7)
Aged
(6)
Depression
(6)
Medical Research
(6)
Mental Health
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Making sense of G-quadruplex and i-motif functions in oncogene promoters

The i-Motif as a Molecular Target: More Than a Complementary DNA Secondary Structure

Identification of natural compounds tubercidin and lycorine HCl against small‐cell lung cancer and BCAT1 as a therapeutic target

Simultaneous Drug Targeting of the Promoter MYC G‑Quadruplex and BCL2 i‑Motif in Diffuse Large B‑Cell Lymphoma Delays Tumor Growth

Oncolytic strategy using new bifunctional HDACs/BRD4 inhibitors against virus-associated lymphomas

The role of G-quadruplex/i-motif secondary structures as cis-acting regulatory elements

Targeting a Novel G-Quadruplex in the CARD11 Oncogene Promoter with Naptho(2,1-b)furan-1-ethanol,2-nitro- Requires the Nitro Group

BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma

The Transcriptional Complex Between the BCL2 i‑Motif and hnRNP LL Is a Molecular Switch for Control of Gene Expression That Can Be Modulated by Small Molecules

The Anti-COVID-19 Drug Remdesivir Promotes Oncogenic Herpesvirus Reactivation through Regulation of Intracellular Signaling Pathways

G4 Biology

Mechanistic Insights into Chemoresistance Mediated by Oncogenic Viruses in Lymphomas

The Dynamic Character of the BCL2 Promoter i‑Motif Provides a Mechanism for Modulation of Gene Expression by Compounds That Bind Selectively to the Alternative DNA Hairpin Structure

Development of Humanized Diffuse Large B-Cell Lymphoma Mouse Models

Discovery of DNA G-Quadruplexes As a New Target for B-Cell Receptor Signaling Inhibition in Diffuse Large B-Cell Lymphoma

Synergistic induction of apoptosis in high-risk DLBCL by BCL2 inhibition with ABT-199 combined with pharmacologic loss of MCL1

The i-Motif in the bcl-2 P1 Promoter Forms an Unexpectedly Stable Structure with a Unique 8:5:7 Loop Folding Pattern

Concomitant Deletion of Short Arm (del 1p) and Amplification or Gain (1q21) of Chromosome 1 By Fluorescence in Situ Hybridization (FISH) Is Associated with Poor Clinical Outcome

Concurrent Targeting of BCL2 and MYC Transcription Leads to Chemo-Sensitization of Dual-Expressing Diffuse Large B-Cell Lymphoma In Vivo

Frequent expression of activation-induced cytidine deaminase in diffuse large B-cell lymphoma tissues from persons living with HIV

Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma

Enhanced DNA repair and genomic stability identify a novel HIV‐related diffuse large B‐cell lymphoma signature

Late Relapsing Multiple Myeloma ≥ 10 Years after Treatment on Total Therapy Protocols Are Associated with Good Outcome

Concurrent BCL2/MYC Gene Amplification Associates with Increased DNA G-Quadruplex Formation in DLBCL

Abstract LB-46: Chemo-sensitization by modulation of Bcl-2 expression: The first example of an i-motif interactive small molecule that modulates gene expression

Suchergebnisse filtern